United States Biotechnology & Medical Research

Regenxbio Inc (RGNX)

Track

Track

Regenxbio Inc. experienced notable insider activity recently, with Gregory Austin Ciongoli acquiring shares worth approximately $949,381 over two late August transactions. This buying follows a period of significant stock price decline. The company's last earnings report showed a substantial EPS beat, though shares remain near their 52-week lows.
Ticker: RGNX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Regenxbio Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Ciongoli Gregory Austin Non-Executive Director
Transaction date
Purchase
Price
207.62
Quantity 98,285 -45.9%
Value US$463,610
Ciongoli Gregory Austin Non-Executive Director
Transaction date
Purchase
Price
269.12
Quantity 23,876 +48.0%
Value US$3,536,182
PAKOLA STEVE Chief Medical Officer Officer
Transaction date
Planned sale
Price
14.34
Quantity 42,724 +37.9%
Value US$4,095,542
PAKOLA STEVE Chief Medical Officer Officer
Transaction date
Planned sale
Price
12.86
Quantity 36,725 -14.7%
Value US$472,284
Stephen J. Pakola Officer Officer
Transaction date
Proposed sale
Price
11.98
Quantity 43,206
Value US$517,608
PAKOLA STEVE Chief Medical Officer Officer
Transaction date
Planned sale
Price
11.04
Quantity 19,608 -8.4%
Value US$216,472
PAKOLA STEVE Chief Medical Officer Officer
Transaction date
Planned sale
Price
11.02
Quantity 15,309 -6.2%
Value US$168,705
STEPHEN PAKOLA Officer Officer
Transaction date
Proposed sale
Price
10.55
Quantity 34,917
Value US$368,374
PAKOLA STEVE Chief Medical Officer Officer
Transaction date
Planned sale
Price
10.35
Quantity 5,124 -2.0%
Value US$53,033
STEPHEN J PAKOLA Officer Officer
Transaction date
Proposed sale
Price
10.38
Quantity 5,124
Value US$53,187
Simpson Curran Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
12.62
Quantity 20,811 -8.8%
Value US$262,635
CURRAN M SIMPSON Director; Officer Executive Director
Transaction date
Proposed sale
Price
12.22
Quantity 20,811
Value US$254,310
Simpson Curran Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
10.03
Quantity 7,624 -3.1%
Value US$76,469
Simpson Curran Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
10.02
Quantity 7,734 -3.1%
Value US$77,495
CURRAN M SIMPSON Director; Officer Executive Director
Transaction date
Proposed sale
Price
9.89
Quantity 15,358
Value US$151,891
Mills Kenneth T. Non-Executive Director
Transaction date
Planned sale
Price
7.91
Quantity 20,602 -4.2%
Value US$163,046
KENNETH MILLS Director Non-Executive Director
Transaction date
Proposed sale
Price
7.52
Quantity 20,602
Value US$154,927
VITTAL VASISTA Officer Officer
Transaction date
Proposed sale
Price
7.41
Quantity 20,041
Value US$148,504
1.6
KARABELAS ARGERIS N Non-Executive Director
Transaction date
Planned sale
Price
10.11
Quantity 10,000 -47.0%
Value US$101,052
1.6
KARABELAS ARGERIS N Non-Executive Director
Transaction date
Planned sale
Price
12.34
Quantity 700 -5.8%
Value US$8,638
1.6
KARABELAS ARGERIS N Non-Executive Director
Transaction date
Planned sale
Price
11.50
Quantity 9,300 -43.7%
Value US$106,950
Simpson Curran Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
15.00
Quantity 100 -0.1%
Value US$1,500
1.6
KARABELAS ARGERIS N Non-Executive Director
Transaction date
Planned sale
Price
15.00
Quantity 100 -0.9%
Value US$1,500
1.6
KARABELAS ARGERIS N Non-Executive Director
Transaction date
Planned sale
Price
14.59
Quantity 400 -3.4%
Value US$5,834
1.6
KARABELAS ARGERIS N Non-Executive Director
Transaction date
Planned sale
Price
13.45
Quantity 9,600 -44.9%
Value US$129,120
1.6
ARGERIS N KARABELAS Director Non-Executive Director
Transaction date
Proposed sale
Price
14.25
Quantity 31,000
Value US$441,750
Simpson Curran Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
15.04
Quantity 9,648 -5.4%
Value US$145,106
1.6
KARABELAS ARGERIS N Non-Executive Director
Transaction date
Planned sale
Price
15.05
Quantity 11,000 -49.4%
Value US$165,495
CURRAN M SIMPSON Director; Officer Executive Director
Transaction date
Proposed sale
Price
14.33
Quantity 25,106
Value US$359,769
Mills Kenneth T. Non-Executive Director
Transaction date
Planned sale
Price
13.96
Quantity 15,369 -3.6%
Value US$214,501
Mills Kenneth T. Non-Executive Director
Transaction date
Planned sale
Price
13.78
Quantity 12,221 -2.9%
Value US$168,433
Mills Kenneth T. Non-Executive Director
Transaction date
Planned sale
Price
13.77
Quantity 2,210 -0.5%
Value US$30,440
Mills Kenneth T. Non-Executive Director
Transaction date
Planned sale
Price
13.76
Quantity 200 -0.0%
Value US$2,752
1.6
KARABELAS ARGERIS N Non-Executive Director
Transaction date
Planned sale
Price
11.27
Quantity 10,000 -47.0%
Value US$112,691
1.6
ARGERIS N KARABELAS Director Non-Executive Director
Transaction date
Proposed sale
Price
11.70
Quantity 30,000
Value US$351,000
Mills Kenneth T. President and CEO Executive Director
Transaction date
Planned sale
Price
15.81
Quantity 15,000 -3.5%
Value US$237,222
KENNETH MILLS Director; Officer Executive Director
Transaction date
Proposed sale
Price
15.74
Quantity 45,000
Value US$708,300
Mills Kenneth T. President and CEO Executive Director
Transaction date
Planned sale
Price
18.19
Quantity 15,000 -3.5%
Value US$272,871
Mills Kenneth T. President and CEO Executive Director
Transaction date
Planned sale
Price
21.86
Quantity 15,000 -3.5%
Value US$327,942
PAKOLA STEVE Chief Medical Officer Officer
Transaction date
Planned sale
Price
28.36
Quantity 12,878 -10.7%
Value US$365,220
STEPHEN J PAKOLA Officer Officer
Transaction date
Proposed sale
Price
21.36
Quantity 12,878
Value US$275,074
Mills Kenneth T. President and CEO Executive Director
Transaction date
Planned sale
Price
16.88
Quantity 10,348 -2.5%
Value US$174,723
Mills Kenneth T. President and CEO Executive Director
Transaction date
Planned sale
Price
16.47
Quantity 4,652 -1.1%
Value US$76,626
Mills Kenneth T. President and CEO Executive Director
Transaction date
Planned sale
Price
15.18
Quantity 45,000 -9.9%
Value US$682,992
KENNETH THOMAS MILLS Director; Officer Executive Director
Transaction date
Proposed sale
Price
15.13
Quantity 90,000
Value US$1,361,700
PAKOLA STEVE Chief Medical Officer Officer
Transaction date
Planned sale
Price
17.39
Quantity 17,237 -13.9%
Value US$299,789
STEPHEN J PAKOLA Officer Officer
Transaction date
Proposed sale
Price
18.34
Quantity 17,237
Value US$316,127
Mills Kenneth T. President and CEO Executive Director
Transaction date
Planned sale
Price
19.69
Quantity 45,000 -11.2%
Value US$885,825
KENNETH THOMAS MILLS Director; Officer Executive Director
Transaction date
Proposed sale
Price
19.51
Quantity 45,000
Value US$877,950
PAKOLA STEVE Chief Medical Officer Officer
Transaction date
Planned sale
Price
22.17
Quantity 3,138 -20.5%
Value US$69,559
Vasista Vittal Chief Financial Officer Officer
Transaction date
Planned sale
Price
30.24
Quantity 2,400 -1.7%
Value US$72,573
Vasista Vittal Chief Financial Officer Officer
Transaction date
Planned sale
Price
35.19
Quantity 17,280 -11.2%
Value US$608,035
Vasista Vittal Chief Financial Officer Officer
Transaction date
Planned sale
Price
35.00
Quantity 400 -0.3%
Value US$14,000
Vasista Vittal Chief Financial Officer Officer
Transaction date
Planned sale
Price
31.26
Quantity 2,400 -1.5%
Value US$75,012
Vasista Vittal Chief Financial Officer Officer
Transaction date
Planned sale
Price
30.00
Quantity 468 -0.3%
Value US$14,040
Vasista Vittal Chief Financial Officer Officer
Transaction date
Planned sale
Price
30.01
Quantity 4,332 -2.7%
Value US$129,988
PAKOLA STEVE Chief Medical Officer Officer
Transaction date
Planned sale
Price
33.75
Quantity 1,598 -16.2%
Value US$53,932
Mills Kenneth T. President and CEO Executive Director
Transaction date
Planned sale
Price
40.00
Quantity 1,500 -0.5%
Value US$60,000
Mills Kenneth T. President and CEO Executive Director
Transaction date
Planned sale
Price
42.19
Quantity 1,500 -0.5%
Value US$63,285
Mills Kenneth T. President and CEO Executive Director
Transaction date
Planned sale
Price
40.25
Quantity 1,500 -0.5%
Value US$60,375
Mills Kenneth T. President and CEO Executive Director
Transaction date
Planned sale
Price
40.02
Quantity 4,500 -1.6%
Value US$180,090
Mills Kenneth T. President and CEO Executive Director
Transaction date
Planned sale
Price
40.77
Quantity 1,500 -0.5%
Value US$61,155
Christmas Patrick J. Chief Legal Officer Officer
Transaction date
Planned sale
Price
49.08
Quantity 4,701 -22.3%
Value US$230,725
Christmas Patrick J. Chief Legal Officer Officer
Transaction date
Planned sale
Price
49.11
Quantity 1,300 -7.4%
Value US$63,843
Christmas Patrick J. Chief Legal Officer Officer
Transaction date
Planned sale
Price
45.13
Quantity 500 -3.0%
Value US$22,565
Christmas Patrick J. Chief Legal Officer Officer
Transaction date
Planned sale
Price
44.77
Quantity 9,500 -36.0%
Value US$425,315
Mills Kenneth T. President and CEO Executive Director
Transaction date
Planned sale
Price
44.99
Quantity 5,211 -1.8%
Value US$234,443
Mills Kenneth T. President and CEO Executive Director
Transaction date
Planned sale
Price
44.05
Quantity 974 -0.3%
Value US$42,905
Mills Kenneth T. President and CEO Executive Director
Transaction date
Planned sale
Price
42.64
Quantity 315 -0.1%
Value US$13,432
Vasista Vittal Chief Financial Officer Officer
Transaction date
Planned sale
Price
50.04
Quantity 252 -0.2%
Value US$12,610
Vasista Vittal Chief Financial Officer Officer
Transaction date
Planned sale
Price
50.03
Quantity 11,093 -8.9%
Value US$554,983
Simpson Curran Chief Oper. & Tech. Officer Officer
Transaction date
Planned sale
Price
50.01
Quantity 11,612 -39.6%
Value US$580,716
Simpson Curran Chief Oper. & Tech. Officer Officer
Transaction date
Planned sale
Price
50.03
Quantity 1,700 -8.7%
Value US$85,051
Vasista Vittal Chief Financial Officer Officer
Transaction date
Planned sale
Price
50.01
Quantity 4,200 -3.3%
Value US$210,042
Christmas Patrick J. Chief Legal Officer Officer
Transaction date
Planned sale
Price
49.15
Quantity 1,378 -7.8%
Value US$67,729
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-27 2026-08-27 B Purchase
Ciongoli Gregory Austin
Non-Executive Director
98,285 -45.9%
207.62
US$463,610 		98,285 -45.9% 207.62 US$463,610
2026-08-27 2026-08-26 B Purchase
Ciongoli Gregory Austin
Non-Executive Director
23,876 +48.0%
269.12
US$3,536,182 		23,876 +48.0% 269.12 US$3,536,182
2026-07-06 2026-07-02 PlS Planned sale
PAKOLA STEVE

Chief Medical Officer

Officer
42,724 +37.9%
14.34
US$4,095,542 		42,724 +37.9% 14.34 US$4,095,542
2026-07-01 2026-07-01 PlS Planned sale
PAKOLA STEVE

Chief Medical Officer

Officer
36,725 -14.7%
12.86
US$472,284 		36,725 -14.7% 12.86 US$472,284
2026-07-01 2026-07-01 PrS Proposed sale
Stephen J. Pakola

Officer

Officer
43,206
11.98
US$517,608 		43,206 11.98 US$517,608
2026-07-01 2026-06-29 PlS Planned sale
PAKOLA STEVE

Chief Medical Officer

Officer
19,608 -8.4%
11.04
US$216,472 		19,608 -8.4% 11.04 US$216,472
2026-05-13 2026-05-11 PlS Planned sale
PAKOLA STEVE

Chief Medical Officer

Officer
15,309 -6.2%
11.02
US$168,705 		15,309 -6.2% 11.02 US$168,705
2026-05-11 2026-05-11 PrS Proposed sale
STEPHEN PAKOLA

Officer

Officer
34,917
10.55
US$368,374 		34,917 10.55 US$368,374
2026-03-12 2026-03-10 PlS Planned sale
PAKOLA STEVE

Chief Medical Officer

Officer
5,124 -2.0%
10.35
US$53,033 		5,124 -2.0% 10.35 US$53,033
2026-03-10 2026-03-10 PrS Proposed sale
STEPHEN J PAKOLA

Officer

Officer
5,124
10.38
US$53,187 		5,124 10.38 US$53,187
2025-10-10 2025-10-09 PlS Planned sale
Simpson Curran

Chief Executive Officer

Executive Director
20,811 -8.8%
12.62
US$262,635 		20,811 -8.8% 12.62 US$262,635
2025-10-09 2025-10-09 PrS Proposed sale
CURRAN M SIMPSON

Director; Officer

Executive Director
20,811
12.22
US$254,310 		20,811 12.22 US$254,310
2025-10-01 2025-09-29 PlS Planned sale
Simpson Curran

Chief Executive Officer

Executive Director
7,624 -3.1%
10.03
US$76,469 		7,624 -3.1% 10.03 US$76,469
2025-09-12 2025-09-10 PlS Planned sale
Simpson Curran

Chief Executive Officer

Executive Director
7,734 -3.1%
10.02
US$77,495 		7,734 -3.1% 10.02 US$77,495
2025-09-10 2025-09-10 PrS Proposed sale
CURRAN M SIMPSON

Director; Officer

Executive Director
15,358
9.89
US$151,891 		15,358 9.89 US$151,891
2025-05-14 2025-05-12 PlS Planned sale
Mills Kenneth T.
Non-Executive Director
20,602 -4.2%
7.91
US$163,046 		20,602 -4.2% 7.91 US$163,046
2025-05-12 2025-05-12 PrS Proposed sale
KENNETH MILLS

Director

Non-Executive Director
20,602
7.52
US$154,927 		20,602 7.52 US$154,927
2024-12-30 2024-12-30 PrS Proposed sale
VITTAL VASISTA

Officer

Officer
20,041
7.41
US$148,504 		20,041 7.41 US$148,504
2024-10-02 2024-10-01 PlS Planned sale
1.6
KARABELAS ARGERIS N
Non-Executive Director
10,000 -47.0%
10.11
US$101,052 		10,000 -47.0% 10.11 US$101,052
2024-09-04 2024-09-03 PlS Planned sale
1.6
KARABELAS ARGERIS N
Non-Executive Director
700 -5.8%
12.34
US$8,638 		700 -5.8% 12.34 US$8,638
2024-09-04 2024-09-03 PlS Planned sale
1.6
KARABELAS ARGERIS N
Non-Executive Director
9,300 -43.7%
11.50
US$106,950 		9,300 -43.7% 11.50 US$106,950
2024-08-05 2024-08-01 PlS Planned sale
Simpson Curran

Chief Executive Officer

Executive Director
100 -0.1%
15.00
US$1,500 		100 -0.1% 15.00 US$1,500
2024-08-05 2024-08-01 PlS Planned sale
1.6
KARABELAS ARGERIS N
Non-Executive Director
100 -0.9%
15.00
US$1,500 		100 -0.9% 15.00 US$1,500
2024-08-05 2024-08-01 PlS Planned sale
1.6
KARABELAS ARGERIS N
Non-Executive Director
400 -3.4%
14.59
US$5,834 		400 -3.4% 14.59 US$5,834
2024-08-05 2024-08-01 PlS Planned sale
1.6
KARABELAS ARGERIS N
Non-Executive Director
9,600 -44.9%
13.45
US$129,120 		9,600 -44.9% 13.45 US$129,120
2024-08-01 2024-08-01 PrS Proposed sale
1.6
ARGERIS N KARABELAS

Director

Non-Executive Director
31,000
14.25
US$441,750 		31,000 14.25 US$441,750
2024-07-30 2024-07-29 PlS Planned sale
Simpson Curran

Chief Executive Officer

Executive Director
9,648 -5.4%
15.04
US$145,106 		9,648 -5.4% 15.04 US$145,106
2024-07-30 2024-07-29 PlS Planned sale
1.6
KARABELAS ARGERIS N
Non-Executive Director
11,000 -49.4%
15.05
US$165,495 		11,000 -49.4% 15.05 US$165,495
2024-07-29 2024-07-29 PrS Proposed sale
CURRAN M SIMPSON

Director; Officer

Executive Director
25,106
14.33
US$359,769 		25,106 14.33 US$359,769
2024-07-26 2024-07-25 PlS Planned sale
Mills Kenneth T.
Non-Executive Director
15,369 -3.6%
13.96
US$214,501 		15,369 -3.6% 13.96 US$214,501
2024-07-26 2024-07-24 PlS Planned sale
Mills Kenneth T.
Non-Executive Director
12,221 -2.9%
13.78
US$168,433 		12,221 -2.9% 13.78 US$168,433
2024-07-18 2024-07-17 PlS Planned sale
Mills Kenneth T.
Non-Executive Director
2,210 -0.5%
13.77
US$30,440 		2,210 -0.5% 13.77 US$30,440
2024-07-18 2024-07-16 PlS Planned sale
Mills Kenneth T.
Non-Executive Director
200 -0.0%
13.76
US$2,752 		200 -0.0% 13.76 US$2,752
2024-07-03 2024-07-01 PlS Planned sale
1.6
KARABELAS ARGERIS N
Non-Executive Director
10,000 -47.0%
11.27
US$112,691 		10,000 -47.0% 11.27 US$112,691
2024-07-01 2024-07-01 PrS Proposed sale
1.6
ARGERIS N KARABELAS

Director

Non-Executive Director
30,000
11.70
US$351,000 		30,000 11.70 US$351,000
2024-05-16 2024-05-14 PlS Planned sale
Mills Kenneth T.

President and CEO

Executive Director
15,000 -3.5%
15.81
US$237,222 		15,000 -3.5% 15.81 US$237,222
2024-05-14 2024-05-14 PrS Proposed sale
KENNETH MILLS

Director; Officer

Executive Director
45,000
15.74
US$708,300 		45,000 15.74 US$708,300
2024-04-17 2024-04-15 PlS Planned sale
Mills Kenneth T.

President and CEO

Executive Director
15,000 -3.5%
18.19
US$272,871 		15,000 -3.5% 18.19 US$272,871
2024-03-18 2024-03-14 PlS Planned sale
Mills Kenneth T.

President and CEO

Executive Director
15,000 -3.5%
21.86
US$327,942 		15,000 -3.5% 21.86 US$327,942
2024-03-07 2024-03-05 PlS Planned sale
PAKOLA STEVE

Chief Medical Officer

Officer
12,878 -10.7%
28.36
US$365,220 		12,878 -10.7% 28.36 US$365,220
2024-03-05 2024-03-05 PrS Proposed sale
STEPHEN J PAKOLA

Officer

Officer
12,878
21.36
US$275,074 		12,878 21.36 US$275,074
2024-02-16 2024-02-14 PlS Planned sale
Mills Kenneth T.

President and CEO

Executive Director
10,348 -2.5%
16.88
US$174,723 		10,348 -2.5% 16.88 US$174,723
2024-02-16 2024-02-14 PlS Planned sale
Mills Kenneth T.

President and CEO

Executive Director
4,652 -1.1%
16.47
US$76,626 		4,652 -1.1% 16.47 US$76,626
2024-01-18 2024-01-16 PlS Planned sale
Mills Kenneth T.

President and CEO

Executive Director
45,000 -9.9%
15.18
US$682,992 		45,000 -9.9% 15.18 US$682,992
2024-01-16 2024-01-16 PrS Proposed sale
KENNETH THOMAS MILLS

Director; Officer

Executive Director
90,000
15.13
US$1,361,700 		90,000 15.13 US$1,361,700
2024-01-04 2024-01-03 PlS Planned sale
PAKOLA STEVE

Chief Medical Officer

Officer
17,237 -13.9%
17.39
US$299,789 		17,237 -13.9% 17.39 US$299,789
2024-01-03 2024-01-03 PrS Proposed sale
STEPHEN J PAKOLA

Officer

Officer
17,237
18.34
US$316,127 		17,237 18.34 US$316,127
2023-12-21 2023-12-19 PlS Planned sale
Mills Kenneth T.

President and CEO

Executive Director
45,000 -11.2%
19.69
US$885,825 		45,000 -11.2% 19.69 US$885,825
2023-12-19 2023-12-19 PrS Proposed sale
KENNETH THOMAS MILLS

Director; Officer

Executive Director
45,000
19.51
US$877,950 		45,000 19.51 US$877,950
2023-01-05 2023-01-03 PlS Planned sale
PAKOLA STEVE

Chief Medical Officer

Officer
3,138 -20.5%
22.17
US$69,559 		3,138 -20.5% 22.17 US$69,559
2022-08-31 2022-08-30 PlS Planned sale
Vasista Vittal

Chief Financial Officer

Officer
2,400 -1.7%
30.24
US$72,573 		2,400 -1.7% 30.24 US$72,573
2022-08-08 2022-08-05 PlS Planned sale
Vasista Vittal

Chief Financial Officer

Officer
17,280 -11.2%
35.19
US$608,035 		17,280 -11.2% 35.19 US$608,035
2022-08-08 2022-08-04 PlS Planned sale
Vasista Vittal

Chief Financial Officer

Officer
400 -0.3%
35.00
US$14,000 		400 -0.3% 35.00 US$14,000
2022-08-03 2022-08-01 PlS Planned sale
Vasista Vittal

Chief Financial Officer

Officer
2,400 -1.5%
31.26
US$75,012 		2,400 -1.5% 31.26 US$75,012
2022-07-15 2022-07-14 PlS Planned sale
Vasista Vittal

Chief Financial Officer

Officer
468 -0.3%
30.00
US$14,040 		468 -0.3% 30.00 US$14,040
2022-07-15 2022-07-13 PlS Planned sale
Vasista Vittal

Chief Financial Officer

Officer
4,332 -2.7%
30.01
US$129,988 		4,332 -2.7% 30.01 US$129,988
2022-01-04 2022-01-03 PlS Planned sale
PAKOLA STEVE

Chief Medical Officer

Officer
1,598 -16.2%
33.75
US$53,932 		1,598 -16.2% 33.75 US$53,932
2021-11-10 2021-11-08 PlS Planned sale
Mills Kenneth T.

President and CEO

Executive Director
1,500 -0.5%
40.00
US$60,000 		1,500 -0.5% 40.00 US$60,000
2021-09-29 2021-09-27 PlS Planned sale
Mills Kenneth T.

President and CEO

Executive Director
1,500 -0.5%
42.19
US$63,285 		1,500 -0.5% 42.19 US$63,285
2021-06-28 2021-06-25 PlS Planned sale
Mills Kenneth T.

President and CEO

Executive Director
1,500 -0.5%
40.25
US$60,375 		1,500 -0.5% 40.25 US$60,375
2021-06-28 2021-06-24 PlS Planned sale
Mills Kenneth T.

President and CEO

Executive Director
4,500 -1.6%
40.02
US$180,090 		4,500 -1.6% 40.02 US$180,090
2021-03-01 2021-02-25 PlS Planned sale
Mills Kenneth T.

President and CEO

Executive Director
1,500 -0.5%
40.77
US$61,155 		1,500 -0.5% 40.77 US$61,155
2021-02-17 2021-02-12 PlS Planned sale
Christmas Patrick J.

Chief Legal Officer

Officer
4,701 -22.3%
49.08
US$230,725 		4,701 -22.3% 49.08 US$230,725
2021-02-10 2021-02-08 PlS Planned sale
Christmas Patrick J.

Chief Legal Officer

Officer
1,300 -7.4%
49.11
US$63,843 		1,300 -7.4% 49.11 US$63,843
2021-02-04 2021-02-02 PlS Planned sale
Christmas Patrick J.

Chief Legal Officer

Officer
500 -3.0%
45.13
US$22,565 		500 -3.0% 45.13 US$22,565
2021-02-04 2021-02-02 PlS Planned sale
Christmas Patrick J.

Chief Legal Officer

Officer
9,500 -36.0%
44.77
US$425,315 		9,500 -36.0% 44.77 US$425,315
2021-01-27 2021-01-25 PlS Planned sale
Mills Kenneth T.

President and CEO

Executive Director
5,211 -1.8%
44.99
US$234,443 		5,211 -1.8% 44.99 US$234,443
2021-01-27 2021-01-25 PlS Planned sale
Mills Kenneth T.

President and CEO

Executive Director
974 -0.3%
44.05
US$42,905 		974 -0.3% 44.05 US$42,905
2021-01-27 2021-01-25 PlS Planned sale
Mills Kenneth T.

President and CEO

Executive Director
315 -0.1%
42.64
US$13,432 		315 -0.1% 42.64 US$13,432
2021-01-20 2021-01-15 PlS Planned sale
Vasista Vittal

Chief Financial Officer

Officer
252 -0.2%
50.04
US$12,610 		252 -0.2% 50.04 US$12,610
2021-01-14 2021-01-14 PlS Planned sale
Vasista Vittal

Chief Financial Officer

Officer
11,093 -8.9%
50.03
US$554,983 		11,093 -8.9% 50.03 US$554,983
2021-01-14 2021-01-14 PlS Planned sale
Simpson Curran

Chief Oper. & Tech. Officer

Officer
11,612 -39.6%
50.01
US$580,716 		11,612 -39.6% 50.01 US$580,716
2021-01-14 2021-01-12 PlS Planned sale
Simpson Curran

Chief Oper. & Tech. Officer

Officer
1,700 -8.7%
50.03
US$85,051 		1,700 -8.7% 50.03 US$85,051
2021-01-14 2021-01-12 PlS Planned sale
Vasista Vittal

Chief Financial Officer

Officer
4,200 -3.3%
50.01
US$210,042 		4,200 -3.3% 50.01 US$210,042
2021-01-12 2021-01-12 PlS Planned sale
Christmas Patrick J.

Chief Legal Officer

Officer
1,378 -7.8%
49.15
US$67,729 		1,378 -7.8% 49.15 US$67,729
Explore more

More insider trading research around Regenxbio Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America